Sign in

CIK 0001671858

  • Non-accelerated filer
  • Smaller reporting company

ARS Pharmaceuticals, Inc.

Sign in to watch
Ticker
SPRY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811489190
Phone
+1 858-771-9307
Business address
11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
Former names
Silverback Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-02-01 Hawkinson Russ Sr. Vice President of Finance Grant or award · Stock Option (right to buy) +45,000 45,000
2022-02-01 Hawkinson Russ Sr. Vice President of Finance Grant or award · Stock Option (right to buy) +28,500 28,500
2022-02-01 Piazza Jonathan Chief Financial Officer Grant or award +11,250 25,534
2022-02-01 Piazza Jonathan Chief Financial Officer Grant or award · Stock Option (right to buy) +67,500 67,500
2022-02-01 Piazza Jonathan Chief Financial Officer Grant or award · Stock Option (right to buy) +42,750 42,750
2022-02-01 Hunder Naomi Chief Medical Officer Grant or award +11,250 11,250
2022-02-01 Hunder Naomi Chief Medical Officer Grant or award · Stock Option (right to buy) +67,500 67,500
2022-02-01 Hunder Naomi Chief Medical Officer Grant or award · Stock Option (right to buy) +42,750 42,750
2022-02-01 Shawver Laura Chief Executive Officer Grant or award +27,500 107,395
2022-02-01 Shawver Laura Chief Executive Officer Grant or award · Stock Option (right to buy) +165,000 165,000
2022-02-01 Shawver Laura Chief Executive Officer Grant or award · Stock Option (right to buy) +104,500 104,500
2022-02-01 Odegard Valerie President and CSO Grant or award +16,406 16,406
2022-02-01 Odegard Valerie President and CSO Grant or award · Stock Option (right to buy) +98,438 98,438
2022-02-01 Odegard Valerie President and CSO Grant or award · Stock Option (right to buy) +49,875 49,875
2021-12-13 ROOT JONATHAN D Director Other disposition −2,069,167 0
2021-12-13 ROOT JONATHAN D Director Other disposition −105,012 0
2021-11-15 ROOT JONATHAN D Director Purchase +2,014 $8.85 $18K 2,364
2021-06-04 Thompson Peter A. Director Grant or award · Stock Option (right to buy) +15,000 15,000
2021-06-04 ROOT JONATHAN D Director Grant or award · Stock Option (right to buy) +15,000 15,000
2021-06-04 Powell Andrew Kenneth William Director Grant or award · Stock Option (right to buy) +15,000 15,000

Page 27 of 31 · 602 trades